Genomics

Clinical Trial Sequencing Project - Diffuse Large B-Cell Lymphoma

The goal of the project is to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures. National Cancer Institute (NCI) utilized whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing. The samples were processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project.

Listed for discovery. Access is provided by the original publisher under its terms.

Data coverage

The goal of the project is to identify recurrent genetic alterations (mutations, deletions, amplifications, rearrangements) and/or gene expression signatures. National Cancer Institute (NCI) utilized whole genome sequencing and/or whole exome sequencing in conjunction with transcriptome sequencing. The samples were processed and submitted for genomic characterization using pipelines and procedures established within The Cancer Genome Analysis (TCGA) project.

Access & permitted use

Review the publisher’s documentation for availability, eligibility and permitted uses, including commercial analysis, model training and redistribution.

NIH Genomic Data Sharing Policy: https://gdc.cancer.gov/access-data/data-access-policies

Need help sourcing data?

Tell us your required fields, population, geography and time period. We can review suitable sources and licensing options.

Request sourcing help

Related data sources